A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy‐associated secondary immunodeficiency
A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy‐associated secondary immunodeficiency
复制标题
法国的一项观察性研究描述了人类多价免疫球蛋白在血液恶性肿瘤相关继发性免疫缺陷中的应用
DOI：
--
复制
发表时间：
2018
影响因子：
3.1
通讯作者：
V. Lévy
中科院分区：
文献类型：
--
作者：
O. Benbrahim;J. Viallard;S. Choquet;B. Royer;F. Bauduer;O. Decaux;J. Crave;Y. Fardini;P. Clerson;V. Lévy
描述与血液恶性肿瘤（HM）相关的继发性免疫缺陷（SID）患者开始免疫球蛋白替代治疗（IgRT）的特征、医生对IgRT的期望和IgRT方式。
To describe the characteristics of patients suffering from secondary immunodeficiencies (SID) associated with hematological malignancies (HM), who started immunoglobulin replacement therapy (IgRT), physicians’ expectations regarding IgRT, and IgRT modalities.